Hygieia, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
9
Ending by 2030
Apr 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 2, 2027The maintenance fee for Apparatus for Optimizing a Patient's Insulin Dosage Regimen (US 10,335,546) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 1 fee due Feb 15, 2027The maintenance fee for Systems, Devices, and Methods for Alleviating Glucotoxicity and Restoring Pancreatic Beta-Cell Function in Advanced Diabetes Mellitus (US 11,723,592) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Apparatus for Optimizing A Patient's Insulin Dosage Regimen (US 11,756,661) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 2 fees due May 28, 2027
- 1 fee due Jun 29, 2027The maintenance fee for Systems, Methods and Devices for Achieving Glycemic Balance (US 9,220,456) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Jul 9, 2027The maintenance fee for System for optimizing a patient's insulin dosage regimen (US 11,869,648) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 1 fee due Oct 21, 2027The maintenance fee for Systems, Devices, and Methods for Alleviating Glucotoxicity and Restoring Pancreatic Beta-Cell Function in Advanced Diabetes Mellitus (US 10,624,577) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
- 1 fee due Nov 17, 2027The maintenance fee for Apparatus and methods for taking blood glucose measurements and recommending insulin doses (US 9,341,614) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,370,077 | System for optimizing a patient's insulin dosage regimen In force · USPTO record | In force | USPTO record | |
| US 12,183,445 | Apparatus for Optimizing A Patient's Insulin Dosage Regimen In force · High confidence | In force | High confidence | |
| US 8,992,464 | Apparatus and System for Diabetes Management In force · High confidence | In force | High confidence | |
| US 10,736,562 | Systems, Methods and Devices for Achieving Glycemic Balance In force · High confidence | In force | High confidence | |
| US 10,335,546 | Apparatus for Optimizing a Patient's Insulin Dosage Regimen In force · Medium confidence | In force | Medium confidence | |
| US 11,756,661 | Apparatus for Optimizing A Patient's Insulin Dosage Regimen In force · High confidence | In force | High confidence | |
| US 11,826,163 | Systems, Methods and Devices for Achieving Glycemic Balance In force · High confidence | In force | High confidence | |
| US 10,679,747 | Apparatus and Methods for Taking Blood Glucose Measurements and Recommending Insulin Doses In force · High confidence | In force | High confidence | |
| US 11,826,142 | Apparatus and Method for Taking Blood Glucose Measurements and Recommending Insulin Doses In force · High confidence | In force | High confidence | |
| US 10,272,198 | System for optimizing a patient's insulin dosage regimen In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 16: 4 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned · 2 no status recorded